Total Payments
$19,849
2024 Payments
$2,027
Companies
48
Transactions
868
Medicare Patients
3,845
Medicare Billing
$257,668
Payment Breakdown by Category
Food & Beverage$14,535 (73.2%)
Other$3,607 (18.2%)
Travel$881.49 (4.4%)
Education$476.08 (2.4%)
Consulting$350.00 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,535 | 822 | 73.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,160 | 1 | 15.9% |
| Travel and Lodging | $881.49 | 4 | 4.4% |
| Education | $476.08 | 38 | 2.4% |
| Honoraria | $350.00 | 1 | 1.8% |
| Consulting Fee | $350.00 | 1 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96.64 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,632 | 36 | $0 (2024) |
| ABBVIE INC. | $3,330 | 193 | $0 (2024) |
| PFIZER INC. | $1,091 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $997.86 | 45 | $0 (2024) |
| Lilly USA, LLC | $876.17 | 50 | $0 (2024) |
| PruGen, Inc. Pharmaceuticals | $734.88 | 31 | $0 (2020) |
| Biofrontera Inc. | $619.44 | 9 | $0 (2024) |
| Promius Pharma LLC | $572.28 | 8 | $0 (2018) |
| Dermavant Sciences, Inc. | $541.51 | 48 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $537.51 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,027 | 115 | ABBVIE INC. ($438.19) |
| 2023 | $1,834 | 104 | Janssen Biotech, Inc. ($391.27) |
| 2022 | $1,807 | 85 | ABBVIE INC. ($447.91) |
| 2021 | $1,447 | 76 | AbbVie Inc. ($746.85) |
| 2020 | $1,190 | 63 | AbbVie Inc. ($291.44) |
| 2019 | $2,119 | 112 | AbbVie, Inc. ($372.21) |
| 2018 | $1,992 | 138 | AbbVie, Inc. ($408.05) |
| 2017 | $7,433 | 175 | Novartis Pharmaceuticals Corporation ($4,201) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.17 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.58 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.09 | General |
| 10/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: DERMATOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.58 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 992 | 1,796 | $197,764 | $66,663 |
| 2022 | 11 | 945 | 1,801 | $182,883 | $63,847 |
| 2021 | 13 | 977 | 1,697 | $197,859 | $68,341 |
| 2020 | 11 | 931 | 1,642 | $190,100 | $58,818 |
Total Patients
3,845
Total Services
6,936
Medicare Billing
$257,668
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 287 | 387 | $61,727 | $22,338 | 36.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 183 | 243 | $35,211 | $9,957 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 110 | $25,905 | $9,520 | 36.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 116 | 132 | $25,885 | $8,812 | 34.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 46 | 55 | $13,624 | $3,975 | 29.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 139 | 706 | $8,190 | $3,386 | 41.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 64 | $6,774 | $2,246 | 33.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 25 | 25 | $6,163 | $2,075 | 33.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 37 | $3,541 | $1,608 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,779 | $1,581 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,967 | $1,165 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 269 | 374 | $59,443 | $22,238 | 37.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 188 | 250 | $36,177 | $10,736 | 29.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 99 | 114 | $22,287 | $7,502 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 65 | $15,308 | $5,706 | 37.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 149 | 769 | $8,917 | $3,857 | 43.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 37 | 44 | $10,899 | $3,550 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 56 | $5,328 | $2,347 | 44.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 42 | 66 | $6,929 | $2,178 | 31.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 12 | 17 | $6,554 | $2,163 | 33.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 24 | 25 | $6,076 | $2,088 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,967 | $1,482 | 29.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 266 | 370 | $59,015 | $22,207 | 37.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 188 | 252 | $36,515 | $10,579 | 29.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 102 | 117 | $22,944 | $8,266 | 36.0% |
About Dr. Wayne Breer, MD
Dr. Wayne Breer, MD is a Dermatology healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255324703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Breer, MD has received a total of $19,849 in payments from pharmaceutical and medical device companies, with $2,027 received in 2024. These payments were reported across 868 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($14,535).
As a Medicare-enrolled provider, Breer has provided services to 3,845 Medicare beneficiaries, totaling 6,936 services with total Medicare billing of $257,668. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Chesterfield, MO
- Active Since 08/30/2005
- Last Updated 04/03/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1255324703
Products in Payments
- COSENTYX (Biological) $4,577
- SKYRIZI (Biological) $1,631
- EUCRISA (Drug) $1,057
- Humira (Biological) $970.39
- TALTZ (Drug) $876.17
- TREMFYA (Drug) $642.60
- Otezla (Drug) $602.16
- Ameluz (Drug) $556.33
- VTAMA (Drug) $541.51
- Cloderm Cream (Drug) $470.98
- RINVOQ (Biological) $378.39
- ENSTILAR (Drug) $362.58
- OPZELURA (Drug) $328.33
- HUMIRA (Biological) $283.66
- DORYX (Drug) $264.57
- Cimzia (Drug) $207.75
- DUPIXENT (Biological) $201.18
- LIBTAYO (Biological) $200.77
- REMICADE (Biological) $193.68
- Sotyktu (Drug) $189.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chesterfield
Dr. Mark Kory, M.d, M.D
Dermatology — Payments: $212,129
Dermatology $212,129
Daniel Ring, Md, MD
Dermatology — Payments: $19,227
Dermatology $19,227
Lawrence Samuels, M.d, M.D
Dermatology — Payments: $18,199
Dermatology $18,199
Joseph Muccini, M.d, M.D
Dermatology — Payments: $17,150
Dermatology $17,150
Dr. Pooja Dorward, M.d, M.D
Dermatology — Payments: $10,002
Dermatology $10,002
Dr. James Donnelly, Md, MD
Dermatology — Payments: $3,254
Dermatology $3,254